Victoza 6 mg/mL Subcutaneous Injection, 2 Pens/Pack

Victoza — 6MG/ML, Injection, carton of 2 × 3 mL syringes

Victoza (liraglutide) is a injection for subcutaneous use. VICTOZA is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus, • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. Limitations of Use: VICTOZA contains liraglutide.

• Active ingredient or product type: LIRAGLUTIDE
• Strength/concentration: 6MG/ML
• Dosage form and route: Injection, Subcutaneous
• Exact package presentation: carton of 2 × 3 mL syringes
• NDC/item number: 0169-4060-12
• Manufacturer: NOVO NORDISK INC
• Storage/handling: stored in a refrigerator between 36ºF to 46ºF (2ºC to 8ºC). store in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze VICTOZA and do not use VICTOZA if it has been frozen.
• Status: Rx only

Important safety information: • Acute Pancreatitis : Has been observed in patients treated with GLP-1 receptor agonists, including VICTOZA.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.